How to Buy Indivior Pharmaceuticals Stock
Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence.
Indivior Pharmaceuticals stock last closed at $37.46, down 0.35% from the previous day, and has increased 231.8% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 2.61 percentage points. Indivior Pharmaceuticals stock is currently +238.09% from its 52-week low of $11.08, and -8.63% from its 52-week high of $41.00.
At the moment, there are 121.92M shares of INDV outstanding. The market capitalization of INDV is $4.57B. In the last 24 hours, 1.21M INDV shares were traded.
How to Buy Indivior Pharmaceuticals Stock
Wondering how to invest in Indivior Pharmaceuticals stock? Here's how.
- Figure out where to buy Indivior Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Indivior Pharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Research Indivior Pharmaceuticals stock: The Indivior Pharmaceuticals ticker symbol is INDV. Is Indivior Pharmaceuticals stock a good investment? Should you buy shares of INDV? How do INDV's underlying business fundamentals look? Do top analysts think Indivior Pharmaceuticals is a good buy? Why has INDV's stock price moved recently? (Hint: Our stock market analysis website can help you understand if INDV is a good stock to buy).
- Make your INDV buy order: Decide if you will purchase INDV shares at the current market price or use a limit order to buy INDV stock at a specific price.
- Get the latest news on your investment in INDV: Create a watchlist to watch your investment in Indivior Pharmaceuticals shares.
Step 1: Figure out where to buy Indivior Pharmaceuticals stock
You need a brokerage account to access the NASDAQ market and buy INDV shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal information so you are able to invest in INDV today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new trading account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've created your account on the best investment app, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of transferring money into your investment account.
Step 4: Research Indivior Pharmaceuticals stock
Once you have selected the best place to buy Indivior Pharmaceuticals stock, it's crucial to research their stock before you invest, so you actually wrap your head around the risk and opportunity.
Indivior Pharmaceuticals quick stats
Fundamentals of Indivior Pharmaceuticals
WallStreetZen was created to help everyday investors perform better fundamental analysis.
You can see all of the due diligence checks on INDV's stock page.
Is INDV stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge INDV's fair value.
Using relative valuations ratios:
- INDV could be overvalued based on its P/E ratio of 18.64x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 10.9x
- INDV may be undervalued based on its PEG ratio of 0.69x
You can access additional valuation research on INDV's stock here.
INDV Financials at a glance
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the INDV balance sheet.
- INDV profit margin has gone up from -0.6% to 19.4% in the past year.
- INDV has $175.00M in cash and short term investments. This is enough to cover its annual cash burn of $192.00M.
Negative Health Checks:
- Total INDV debt is still negative.
- INDV debt to equity ratio of -9.31 is negative.
- There are more short-term liabilities than short-term assets on the INDV balance sheet.
- INDV has cash burn of 192000000. It does not have enough cash and short-term investments to cover this.
Is Indivior Pharmaceuticals stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Equities analysts who give ratings on INDV, the consensus analyst rating on Indivior Pharmaceuticals is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Indivior Pharmaceuticals stock forecast page.
INDV Technical Indicators
INDV Growth Numbers
Last year, INDV revenue was $1.29B. Over the last 3 year, INDV's revenue has increased by 71.26% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 8.13%.
Learn more about INDV's earnings and revenue performance here.
Latest Insiders Trades at INDV
In the last 12 months, insiders at INDV have sold more shares than they have bought.
Juliet Thompson, Director of INDV, was the latest INDV insider to sell. They sold $42,758.76 worth of INDV shares on May 12, 2026.
Get more info about who owns INDV stock here.
Does INDV stock generate passive income?
No, Indivior Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about INDV
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your INDV buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular price limit, place a limit order.
Click the Open Trade button and your broker will place your order.
If you want more assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in INDV
Now that you own some shares in INDV, you'll want to keep up with your new investment.
Create a watchlist to get notified of the latest news about your INDV stock.
INDV Feed
How to Buy Stock in Indivior Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Indivior Pharmaceuticals:
- Figure out where to buy Indivior Pharmaceuticals stock
- Open your brokerage account
- Put funds into your brokerage account
- Research Indivior Pharmaceuticals stock
- Make your INDV buy order
- Get the latest news on your investment in INDV
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your investment in Indivior Pharmaceuticals, create a watchlist on WallStreetZen today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.